您的位置：首页 > 产品中心 > 958293-79-3， (±)-Naproxen-(methoxy-d3)
(±)-Naproxen-(methoxy-d3)
| 产品编号： | 3431059 |
| 规格： | VETRANAL®, analytical standard |
| CAS NO： | 958293-79-3 |
| 包装规格： | 10 MG |
| 产品类别： | 进口试剂 |
| 品牌： | Supelco |
| 优惠价： | 立即咨询 |
产品别名
958293-79-3
(±)-Naproxen-(methoxy-d3)
(RS)-2-[6-(Methoxy-d3)-2-naphthyl]propionic acid
6-(Methoxy-d3)-α-methyl-2-naphthaleneacetic acid
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C14D3H11O3 |
| Molecular weight | 233.28 |
| MDL number | MFCD22572922 |
| PubChem Substance ID【PubChem化学物质编号】 | 329753993 |
| NACRES | NA.24 |
| General description【一般描述】 | (±)-Naproxen-(methoxy-d3) may be used as a reference standard for the determination of (±)-naproxen-(methoxy-d3) in aqueous samples using solid-phase extraction (SPE) followed by ultra performance liquid chromatography-triple quadrupole mass spectrometry (UPLC-QqQ-MS/MS). |
| Application【应用】 | Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. |
| Legal Information【法律信息】 | VETRANAL is a registered trademark of sigma-aldrich Chemie GmbH |
产品性质
| grade【等级】 | analytical standard |
| Quality Level【质量水平】 | 100 |
| product line【产品线】 | VETRANAL® |
| shelf life【保质期】 | limited shelf life, expiry date on the label |
| technique(s) | HPLC: suitable gas chromatography (GC): suitable |
| application(s) | clinical environmental forensics and toxicology pharmaceutical (small molecule) veterinary |
| format【格式】 | neat |
| SMILES string | [2H]C([2H])([2H])Oc1ccc2cc(ccc2c1)C(C)C(O)=O |
| InChI | 1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/i2D3 |
| InChI key | CMWTZPSULFXXJA-BMSJAHLVSA-N |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P264 - P270 - P301 + P310 - P405 - P501 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral |
| Storage Class Code【储存分类代码】 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
